Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- activation marker 1
- Adult 1
- Africa, Western 1
- Amides/therapeutic use 1
- Antiviral Agents/therapeutic use 1
- Article 1
- Biocontainment 1
- Cataract 1
- CD163 1
- Centers for Disease Control and Prevention (U.S.) 1
- Delivery of Health Care 1
- Disease Outbreaks 1
- Ebola 1
- Ebolavirus 3
- Education 1
- Eye 1
- hemophagocytic lymphohistiocytosis 1
- Hemorrhagic Fever, Ebola 3
- HLH 1
- Hospital preparedness/response 1
- Humans 3
- humans 1
- hyperferritinemia 1
- hypertriglyceridemia 1
- Infection Control 1
- Infectious diseases 1
- inflammation 1
- Lassa Fever 1
- Lassa virus/genetics 1
- macrophage 1
- macrophage activation syndrome 1
- Male 1
- MAS 1
- Middle Aged 1
- Nebraska 1
- Personal protective equipment 1
- Polymerase Chain Reaction 1
- Pyrazines/therapeutic use 1
- Research 1
- Ribavirin/therapeutic use 1
- RNA, Viral 1
- sCD25 1
- sCD163 1
- severe disease 1
- Survivors 1
- T cells 1
- Training 1
- United States 1
- viruses 1
- zoonoses 1
Personal Author
Corporate Author
Place as Subject
- Togo 1
Resource Type General
Select all docs (Max 200)
1 -
4 of 4 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- activation marker (1)
- Adult (1)
- Africa, Western (1)
- Amides/therapeutic use (1)
- Antiviral Agents/therapeutic use (1)
- Article (1)
- Biocontainment (1)
- Cataract (1)
- CD163 (1)
- Centers for Disease Control and Prevention (U.S.) (1)
- Delivery of Health Care (1)
- Disease Outbreaks (1)
- Ebola (1)
- Ebolavirus (3)
- Education (1)
- Eye (1)
- hemophagocytic lymphohistiocytosis (1)
- Hemorrhagic Fever, Ebola (3)
- HLH (1)
- Hospital preparedness/response (1)
- Humans (3)
- humans (1)
- hyperferritinemia (1)
- hypertriglyceridemia (1)
- Infection Control (1)
- Infectious diseases (1)
- inflammation (1)
- Lassa Fever (1)
- Lassa virus/genetics (1)
- macrophage (1)
- macrophage activation syndrome (1)
- Male (1)
- MAS (1)
- Middle Aged (1)
- Nebraska (1)
- Personal protective equipment (1)
- Polymerase Chain Reaction (1)
- Pyrazines/therapeutic use (1)
- Research (1)
- Ribavirin/therapeutic use (1)
- RNA, Viral (1)
- sCD25 (1)
- sCD163 (1)
- severe disease (1)
- Survivors (1)
- T cells (1)
- Training (1)
- United States (1)
- viruses (1)
- zoonoses (1)
- :Kratochvil, Christopher J. ;Evans, Laura2017 May/Jun | Health Secur. 15(3):253-260:The National Ebola Training and Education Center (NETEC) was established in 2015 in response to the 2014-2016 Ebola virus disease outbreak in West Afr...
- :Wells, Jill R. ;Crozier, IanJul 2020 | Emerg Infect Dis. 26(7):1553-1556:A 46-year-old patient with previously documented Ebola virus persistence in his ocular fluid, associated with severe panuveitis, developed a visually ...
- :McElroy, Anita K. ;Shrivastava-Ranjan, PunyaFeb 2019 | Emerg Infect Dis. 25(2):290-298:Ebola virus disease (EVD) is associated with elevated cytokine levels, and hypercytokinemia is more pronounced in fatal cases. This type of hyperinfla...
- :Raabe, Vanessa N. ;Kann, GerritSep 01 2017 | Clin Infect Dis. 65(5):855-859.:Two patients with Lassa fever are described who are the first human cases treated with a combination of ribavirin and favipiravir. Both patients survi...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.